HOLX 71.65 (+1.26%)
US4364401012Medical Devices & InstrumentsMedical Instruments & Supplies

Hologic (HOLX) Stock Highlights

71.65 | +1.26%
2024-12-21 00:36:55
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (64% of total sales, boosted by pandemic), breast health (21% of sales, suppressed by pandemic), surgical (12%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firms revenue (75%), followed by Europe (16%), Asia (6%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Statistics

Range Today
70.36 71.95
Volume Today 7.64M
Range 1 Year
70.24 84.67
Volume 1 Year 410.67M
Range 3 Year
59.78 87.88
Volume 3 Year 1.26B
Range 10 Year
25.6 87.88
Volume 10 Year 5.45B

Highlights

Market Capitalization 18.29B (large)
Floating Shares 229.06M
Current Price 71.65
Price To Earnings 23.88
Price To Revenue 4.71
Price To Book 3.69
Earnings Per Share 3.32
Payout Ratio 0%

Performance

Latest +1.26%
1 Month -8.47%
3 Months -12.82%
6 Months +0.62%
1 Year +0.46%
3 Years -7.69%
5 Years +36.48%
10 Years +165.76%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.